GHCM
XENT

Glen Harbor Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Glen Harbor Capital Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,328
Closed -$52K – 1313
2018
Q1 		$52K Sell
1,328
-4,000
-75% -$146K ﹤0.01% 1234
2017
Q4 		$173K Sell
5,328
-2,672
-33% -$80.1K ﹤0.01% 1024
2017
Q3 		$249K Sell
8,000
-992
-11% -$29.4K 0.01% 821
2017
Q2 		$251K Sell
8,992
-3,008
-25% -$68.1K 0.01% 804
2017
Q1 		$206K Hold
12,000
– – 0.01% 733
2016
Q4 		$145K Buy
+12,000
New +$155K ﹤0.01% 782

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Glen Harbor Capital Management's XENT Position: Q2 2018 in Review

Glen Harbor Capital Management sold out of Intersect ENT, Inc (XENT) in Q2 2018, closing a stake of 1,328 shares — an estimated $52K sold.

Glen Harbor Capital Management first reported a position in XENT in Q4 2016 and held it in 6 quarters. The position peaked at $251K in Q2 2017. 160 funds tracked by Wall St. Rank hold XENT as of Q2 2018.

  • Glen Harbor Capital Management reported no remaining Intersect ENT, Inc position as of Q2 2018 after selling out during the quarter.
  • Glen Harbor Capital Management sold 1,328 Intersect ENT, Inc shares in Q2 2018, an estimated $52K.
  • Glen Harbor Capital Management first reported a position in Intersect ENT, Inc in Q4 2016 and held it in 6 quarters.
  • Glen Harbor Capital Management's Intersect ENT, Inc position peaked at $251K in Q2 2017.
  • 160 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2018.

Based on Glen Harbor Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.